Zimbabwe has declined a substantial American health deal worth $367m (272 million pounds) spanning five years because of the United States' request for sensitive data.
This rejection became public after a official document from December was disclosed, indicating that President Emmerson Mnangagwa deemed the deal was "unbalanced".
A government representative later explained that the United States was seeking health data for scientific study and commercial purposes while was unwilling to guarantee the resulting advantages from any future vaccines.
"We are forced to start the difficult and regrettable task of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had provided over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for continued negotiations to find a deal acceptable to both sides so the country's critical HIV programme can be sustained.
Broader Context
This rejection follows a similar situation in neighbouring Kenya, where a court halted a similar deal with the US following legal challenges were filed about the safety of Kenyans' medical information.
Since returning to office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had administered aid for the American government, but Trump argued its spending was "wasteful" and his government was pursuing government-to-government agreements to boost openness and accountability.
Based on reports, Sixteen African countries have so far agreed to these new agreements, constituting over $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"Effectively, our nation would supply the basic resources for scientific discovery without any certainty that the end products would be available to our population if a future health crisis emerge."
National Interest and Global Health
He also said that the US's withdrawal from the global health body and its push of bilateral deals were undermining frameworks previously established via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage potential pandemics.
"This mechanism is intended to ensure that when a country provides its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to create them."
The government's concerns over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We encourage further dialogue with our US partners on how subsequent collaboration could be arranged in a way that honours the independence and interests of both nations."
Health Experts Reaction
Medical experts said it acknowledged the government's concerns, but urged that negotiations should continue given that a large portion of the country's Aids initiatives relied on foreign aid.
"In cases where technical issues exist, including those relating to information security or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," the group said.
The situation highlights the ongoing debate between accepting much-needed foreign assistance and protecting national sovereignty in an increasingly interconnected world.